What is contrast media?
Contrast media is a type of medical imaging contrast agent used to enhance the visibility of internal body structures during medical imaging procedures. Contrast agents are typically injected into the patient intravenously before the imaging procedure. Common types of medical imaging procedures that use contrast media include computed tomography (CT), magnetic resonance imaging (MRI), and angiography.
There are two main types of contrast media: ionic and non-ionic. Ionic contrast media contains iodine, which is absorbed by the body and can cause side effects such as nausea, vomiting, and diarrhea. Non-ionic contrast media does not contain iodine and is less likely to cause side effects.
Why the contrast media market is a good investment opportunity?
The global contrast media market is growing rapidly, due to the increasing use of diagnostic imaging procedures. The major players in this market are GE Healthcare, Bayer AG, and Bracco S.p.A. This article discusses why the contrast media market is a good investment opportunity.
If you're looking for a good investment opportunity, the contrast media market is definitely worth considering. The global market is projected to USD 5.9 billion by 2026 from USD 4.9 billion in 2021, at a CAGR of 3.7% during the forecast period.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=911
There are a number of factors driving this growth, including the increasing prevalence of chronic diseases such as cancer and cardiovascular disease, the aging population, and the growing use of computed tomography (CT) and magnetic resonance imaging (MRI).
The contrast agent market is highly consolidated, with the top three players accounting for over 60% of the market. However, there is still room for smaller players to grow, as the market is expected to continue to expand in the coming years.
The global contrast media/ contrast agents market is consolidated. The prominent players operating in this market include GE Healthcare (US), Bracco Imaging SPA (Italy), Bayer AG (Germany), Guerbet (France), J.B. Chemicals and Pharmaceuticals Ltd. (India), Lantheus Medical Imaging, Inc. (US), Unijules Life Sciences Ltd. (India), and SANOCHEMIA Pharmazeutika GmbH (Austria).
What are the risks and benefits of investing in the contrast media market?
The risks and benefits of investing in the contrast agent market are both significant. On the one hand, the market is growing rapidly and is expected to continue doing so. This provides investors with the opportunity to make a profit. On the other hand, there are a number of risks associated with this type of investment. These include the potential for regulatory changes, the possibility of negative publicity, and the potential for new entrants to enter the market and compete with existing companies.
The contrast media market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America and the Middle East & Africa (MEA). North America was the largest regional market for contrast agents market in 2020. The large share of the North American market can be attributed to presence of major players in the region, high prevalence of chronic disorders, growing geriatric population, and the increasing adoption of minimally invasive procedures.
Request For Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=911
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com
